ArticlePharmaceutics2025

Formulation and Comparative Characterization of SLNs and NLCs for Targeted Co-Delivery of Paclitaxel and Hydroxytyrosol Carboxylic Acid Esters Against Triple-Negative Breast Cancer.

Elena Peira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.